| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-07 |